HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway

BACKGROUND: As one of the most common malignant tumor, colorectal cancer (CRC) continues to have a high incidence and mortality rate. HRK belongs to the BCL-2 protein family, which has been shown to have antitumor effects in prostate cancer. However, its role in colorectal cancer is not yet known. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haowei, Chen, Yujia, Yuan, Qinzi, Chen, Lixia, Dai, Peiling, Li, Xuenong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769574/
https://www.ncbi.nlm.nih.gov/pubmed/36568155
http://dx.doi.org/10.3389/fonc.2022.1053510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769574/
https://www.ncbi.nlm.nih.gov/pubmed/36568155
http://dx.doi.org/10.3389/fonc.2022.1053510

Ejemplares similares